J
Jack V. Tu
Researcher at Sunnybrook Health Sciences Centre
Publications - 97
Citations - 19125
Jack V. Tu is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Population & Retrospective cohort study. The author has an hindex of 47, co-authored 97 publications receiving 17660 citations. Previous affiliations of Jack V. Tu include University Health Network & Women's College, Kolkata.
Papers
More filters
Journal ArticleDOI
Outcome of heart failure with preserved ejection fraction in a population-based study.
R. Sacha Bhatia,Jack V. Tu,Jack V. Tu,Douglas S. Lee,Peter C. Austin,Jiming Fang,Annick Haouzi,Yanyan Gong,Peter P. Liu,Peter P. Liu,Peter P. Liu +10 more
TL;DR: The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups, and the survival of patients with heart failure with preserved ejection fraction was similar to that of Patients with reduced ejections fraction.
Journal ArticleDOI
Advantages and Disadvantages of Using Artificial Neural Networks versus Logistic Regression for Predicting Medical Outcomes
TL;DR: An overview of the features of neural networks and logistic regression is presented, and the advantages and disadvantages of using this modeling technique are discussed.
Journal ArticleDOI
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
TL;DR: Among community-based heart failure patients, factors identifiable within hours of hospital presentation predicted mortality risk at 30 days and 1 year, and the externally validated predictive index may assist clinicians in estimating heart failure mortality risk and in providing quantitative guidance for decision making in heart failure care.
Journal ArticleDOI
Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes
TL;DR: Elderly patients with and without recent ACS have low rates of adherence to statins, which suggests that many patients initiating statin therapy may receive no or limited benefit from statins because of premature discontinuation.
Journal ArticleDOI
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink,Tara Gomes,Dennis T. Ko,Dennis T. Ko,Paul E. Szmitko,Peter C. Austin,Jack V. Tu,Jack V. Tu,David Henry,Alex Kopp,Muhammad Mamdani +10 more
TL;DR: Among patients receiving clopidogrel following acute myocardial infarction, concomitant therapy with proton pump inhibitors other than pantoprazole was associated with a loss of the beneficial effects of clopIDogrel and an increased risk of reinfarction.